✦ LIBER ✦

Poster #S233 ALL-CAUSE DISCONTINUATION AND SAFETY OF ARIPIPRAZOLE ONCE-MONTHLY FOR THE TREATMENT OF SCHIZOPHRENIA: A POOLED ANALYSIS OF TWO DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIALS

✍ Scribed by Eramo, Anna; Fleischhacker, W. Wolfgang; Sanchez, Raymond; Tsai, Lan-Feng; Peters-Strickland, Timothy S.; Baker, Ross A.; Kostic, Dusan; Kane, John M.

Book ID: 122171018
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 89 KB
Volume: 153
Category: Article
ISSN: 0920-9964
DOI: 10.1016/S0920-9964(14)70512-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EPA-0790 – All-cause discontinuation and

EPA-0790 – All-cause discontinuation and safety of aripiprazole once-monthly for the treatment of schizophrenia: A pooled analysis of two double-blind, randomized, controlled trials

✍ Baker, R.; Fleischhacker, W.W.; Sanchez, R.; Tsai, L.F.; Peters-Strickland, T.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 59 KB

A Pooled Analysis of Two Randomized, Dou

A Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials of Milnacipran Monotherapy in the Treatment of Fibromyalgia

✍ Michael E. Geisser; Robert H. Palmer; R. Michael Gendreau; Yong Wang; Daniel J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

The efficacy, safety, and tolerability o

The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: Results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials

✍ Ira D. Glick; Raymond Mankoski; James M. Eudicone; Ronald N. Marcus; Quynh-Van T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Tu1403 Safety and Tolerability Profile o

Tu1403 Safety and Tolerability Profile of Rifaximin for Treatment of IBS Without Constipation: Results of a Pooled Analysis of Double-Blind, Placebo-Controlled Randomized Controlled Trials

✍ Chang, Lin; Chey, William D.; Drossman, Douglas A.; Lembo, Anthony; Pimentel, Ma 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Poster #T13 THE EFFECT OF PREVIOUS DOSE

Poster #T13 THE EFFECT OF PREVIOUS DOSE OR ORAL ARIPIPRAZOLE (10 OR 30 MG/DAY) ON THE EFFICACY AND TOLERABILITY OF ARIPIPRAZOLE ONCE-MONTHLY: RESULTS FROM POST-HOC ANALYSES FROM TWO DOUBLE-BLIND RANDOMIZED CONTROLLED TRIALS

✍ Baker, Ross A.; Eramo, Anna; Nylander, Anna-Greta; Tsai, Lan-Feng; Peters-Strick 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Functional Outcomes with Aripiprazole On

Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia

✍ Fleischhacker, W.W.; Perry, P.; Sanchez, R.; Jin, N.; Peters-Strickland, T.; Joh 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB